# NAPROXEN SODIUM

NDC: 53345-042
Generic name: Naproxen Sodium
Labeler / Manufacturer: Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20180320

FDA application: ANDA208363

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"53345-042"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=53345-042
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d5981dd-e3f5-48a3-a5f1-ce49689cdfac